The Valley Desk

NCT04649112 · Interventional trial

Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies

Overall registry status Completed

Phase 1

Conditions CD19 Expressing Malignancies, Hematologic Malignancy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov